Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

被引：0
|
作者：
Yuru Fan
Xuan Zhang
Qin Zhang
Liang Zheng
Renpeng Zhou
Cheng Sun
Xihan Wang
Ke Song
Zhusheng He
Honghui Wang
Qian Zhang
Wei Hu
机构：
[1] The Second Affiliated Hospital of Anhui Medical University,Department of Clinical Pharmacology
[2] Jiangsu Hengrui Pharmaceuticals Co.,undefined
[3] Ltd,undefined
来源：
Clinical Pharmacokinetics | 2024年 / 63卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 302
页数：9
相关论文
共 50 条
  • [31] A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects
    Ermer, James
    Martin, Patrick
    Corcoran, Mary
    Matsuo, Yumiko
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (01) : 16 - 29
  • [32] Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study
    Zhao, Xue
    Liu, Hongzhong
    Tian, Wei
    Fang, Ligang
    Yu, Mengyang
    Wu, Xiaofei
    Liu, Aijing
    Wan, Ruijie
    Li, Li
    Luo, Jinghui
    Li, Yuqiong
    Liu, Bo
    He, Yu
    Chen, Xiaowen
    Li, Yuan
    Xu, Donghong
    Wang, Hongyun
    Han, Xiaohong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [33] Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Cheng, Jocelyn Y.
    Moline, Margaret
    Zammit, Gary K.
    Filippov, Gleb
    Bsharat, Mohammad
    Hall, Nancy
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 449 - 457
  • [34] Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Jocelyn Y. Cheng
    Margaret Moline
    Gary K. Zammit
    Gleb Filippov
    Mohammad Bsharat
    Nancy Hall
    Clinical Drug Investigation, 2021, 41 : 449 - 457
  • [35] A randomized, double-blind placebo-controlled study of the safety of apadenoson in subjects with mild or moderate asthma
    Williams, S. P.
    Mcardle, J. R.
    Colice, G.
    Lankford, A.
    Kajdasz, D. K.
    Reed, C. R.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A95 - A96
  • [36] Safety and pharmacokinetics of liposomal curcumin in healthy subjects:A randomized placebo-controlled double blind first-in human study.
    Storka, Angela
    Wolzt, Michael
    Vcelar, Brigitta
    Bolger, Gordon
    Majeed, Muhammed
    Helson, Lawrence
    CANCER RESEARCH, 2013, 73 (08)
  • [37] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [38] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Zhao, Qian
    Liu, Hongzhong
    Wang, Zhenlei
    Wang, Teng
    Cui, Cheng
    Wang, Huanhuan
    Li, Lili
    Zhong, Wen
    Jiang, Ji
    Dong, Kai
    Chen, Shuai
    Jin, Chunyan
    Hu, Pei
    ADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198
  • [39] Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Tan, Karen M. L.
    Chee, Jolene
    Lim, Kezlyn L. M.
    Ng, Maisie
    Gong, Min
    Xu, Jia
    Tin, Felicia
    Natarajan, Padmapriya
    Lee, Bee Lan
    Ong, Choon Nam
    Tint, Mya Thway
    Kee, Michelle Z. L.
    Muller-Riemenschneider, Falk
    Gluckman, Peter D.
    Meaney, Michael J.
    Kumar, Mukkesh
    Karnani, Neerja
    Eriksson, Johan G.
    Nandanan, Bindu
    Wyss, Adrian
    Cameron-Smith, David
    NUTRIENTS, 2023, 15 (10)
  • [40] Cardiovascular safety and pharmacokinetics of almotriptan:: a randomized, double-blind, placebo-controlled, crossover clinical trial in healthy volunteers
    Salvà, M
    Jansat, JM
    Martínez-Tobed, A
    CEPHALALGIA, 2003, 23 (07) : 706 - 706
12345